These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9973856)

  • 1. Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives.
    Verheugt F
    Rev Port Cardiol; 1998 Dec; 17(12):959-65. PubMed ID: 9973856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of late thrombolytic perfusion in acute myocardial infarct].
    Gulba DC
    Z Kardiol; 1993; 82 Suppl 2():183-5. PubMed ID: 8328200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
    López Bescós L
    Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy in acute myocardial infarction.
    Huber K; Maurer G
    Semin Thromb Hemost; 1996; 22(1):15-26. PubMed ID: 8711486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti thrombotic therapy after coronary thrombolysis].
    Tani S; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():484-8. PubMed ID: 12735020
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment.
    Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repeat thrombolysis in acute myocardial infarction].
    Sychra M
    Vnitr Lek; 2002 Aug; 48(8):791-3. PubMed ID: 12425212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction. A guide for North Carolina doctors.
    Williams ML; O'Meara JJ; Tate DA; Simpson RJ
    N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis in acute myocardial infarction: current status.
    Kiernan TJ; Gersh BJ
    Med Clin North Am; 2007 Jul; 91(4):617-37; x. PubMed ID: 17640539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
    Harenberg J; Heene DL
    Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracoronary thrombolytic therapy of acute myocardial infarction].
    Astaf'ev VI; Runovich AA; Grigor'ev EG; Kustov VI; Kuril'skaia TE
    Grudn Khir; 1985; (5):58-65. PubMed ID: 3905528
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary thrombolysis: adjuvant medical therapy.
    Theroux P; Roy L
    Can J Cardiol; 1993; 9(6):524-8. PubMed ID: 8221351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.